e-learning
resources
Barcelona 2013
Monday, 09.09.2013
COPD biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Concordance between airway inflammation and health status in COPD patients with bacterial colonisation
R. Singh, A. Mackay, A. Patel, B. Kowlessar, D. Garcha, S. Brill, R. Sapsford, L. Donnelly, P. Barnes, G. Donaldson, J. Wedzicha (London, United Kingdom)
Source:
Annual Congress 2013 –COPD biomarkers
Session:
COPD biomarkers
Session type:
Thematic Poster Session
Number:
2172
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Singh, A. Mackay, A. Patel, B. Kowlessar, D. Garcha, S. Brill, R. Sapsford, L. Donnelly, P. Barnes, G. Donaldson, J. Wedzicha (London, United Kingdom). Concordance between airway inflammation and health status in COPD patients with bacterial colonisation. Eur Respir J 2013; 42: Suppl. 57, 2172
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Clinical characteristics and health status of spontaneous sputum producers in COPD
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015
Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD
Source: Eur Respir J 2004; 23: 685-691
Year: 2004
Impaired health status in primary care COPD patients is underestimated
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015
The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases
Source: International Congress 2014 – Markers
Year: 2014
The pulmonary artery-aorta ratio, exacerbation rate and quality of life in stable COPD patients
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Longitudinal changes in COPD patients in primary care
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Impact on patients' health status following early identification of a COPD exacerbation
Source: Eur Respir J 2007; 30: 907-913
Year: 2007
Impact of preventing exacerbations on deterioration of health status in COPD
Source: Eur Respir J 2004; 23: 698-702
Year: 2004
One-year change in health status and outcomes in chronic obstructive pulmonary disease
Source: International Congress 2014 – Best abstracts in chronic care
Year: 2014
Assessment of quality of life of bronchiectasis patients associated with asthma and COPD.
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019
Impact of lung function impairment and exacerbation history on COPD patient-reported utility
Source: International Congress 2014 – COPD markers
Year: 2014
The impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016
Loneliness and lack of social support severely influences patients’ quality of life. Secondary findings from our focusgroup study in asthma and COPD patients
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Quality of life in obstructive lung diseases
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013
Experiences of well-being when living with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Qualitative and quantitative research that contributes to respiratory nursing practice
Year: 2014
Fatigue and decreased health can predict mortality in COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Is anxiety and depression a barrier to enrolment in a study in chronic obstructive pulmonary disease (COPD)?
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016
Reduction in clinically important deterioration in COPD with aclidinium/formoterol
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
The association between objective CT measures of bronchiectasis and health-related quality of life in COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Predictors of respiratory health status in patients with severe asthma
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept